Neuroprotective effects of linagliptin in a rotenone-induced rat model of Parkinson's disease

The present study investigates the antiParkinsonian activity of dipeptidyl peptidase-4 (DPP-IV) inhibitor, linagliptin. The experimental Parkinson's disease (PD) was induced by administration of rotenone at a dose of 1.5 mg/kg at alternate day subcutaneously for 21 days. Standard drug (levodopa...

Descripción completa

Detalles Bibliográficos
Autores principales: Abhangi, Kinjal V, Patel, Jigneshkumar Ishwarlal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012419/
https://www.ncbi.nlm.nih.gov/pubmed/35343207
http://dx.doi.org/10.4103/ijp.IJP_384_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012419/
https://www.ncbi.nlm.nih.gov/pubmed/35343207
http://dx.doi.org/10.4103/ijp.IJP_384_20

Ejemplares similares